Evidence map›Paper›PMID 36070534›Full record

ArticleJCO global oncology2022

Lessons Learnt From Pilot Cervical Cancer Screening and Treatment Programmes Integrated to Routine Primary Health Care Services in Benin, Cote d'Ivoire, and Senegal.

Farida Selmouni, Catherine Sauvaget, Djima Patrice Dangbemey, Djoukou Denise Olga Kpebo, Ndeye Mbombe Dieng, Eric Lucas, Youssef Chami Khazraji, Maria Bennani, Rachid Bekkali, Partha Basu

Abstract read
In one paragraph

Article in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Colposcopy in the Primary Health Care: A Scoping Review.Journal of primary care & community health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Farida SelmouniEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-2662-1126
Catherine SauvagetEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-8053-4963
Djima Patrice DangbemeyDepartment of Obstetrics and Gynaecology, Lagoon Mother and Child University Hospital Center, Faculty of Health Science, University of Abomey Calavi, Cotonou, Benin.ORCID 0000-0002-6463-2555
Djoukou Denise Olga KpeboNational Institute of Public Health, Abidjan, Cote d'Ivoire.
Ndeye Mbombe DiengDivision of Noncommunicable Disease Control, Senegal Ministry of Health and Social Action, Dakar, Senegal.ORCID 0000-0002-9700-1530
Eric LucasEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-1252-1925
Youssef Chami KhazrajiFoundation Lalla Salma, Cancer Prevention and Treatment, Rabat, Morocco.
Maria BennaniFoundation Lalla Salma, Cancer Prevention and Treatment, Rabat, Morocco.
Rachid BekkaliFoundation Lalla Salma, Cancer Prevention and Treatment, Rabat, Morocco.
Partha BasuEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-0124-4050

Funding

World Health Organization 001
6 · The paper itself

Abstract

purposeThe project aimed to implement pilot screening and treatment services for cervical cancer integrated with existing primary health centers (PHCs) in Benin, Cote d'Ivoire, and Senegal and evaluate these services using implementation research outcomes such as reach, effectiveness, adoption, and acceptability. MATERIALS AND

methodsThe Ministry of Health in each country took the lead in setting up a stakeholder's group that designed a protocol tailored to the local context. The target age was 25-49 years in Benin and Cote d'Ivoire and 30-49 years in Senegal. Visual inspection with acetic acid (VIA) was the screening test, and thermal ablation (TA) was the ablative treatment of choice in all. The Ministry in each country identified 4-5 PHCs to set up screening and ablation services and one higher-level center for colposcopy referral. After a master-trainer led training program, nurses, midwives, or general practitioners screened opportunistically the eligible women attending the clinics. The VIA-positive women eligible for ablation were offered immediate treatment.

resultsBetween May 2018 and January 2021, 16,530 women were screened opportunistically. VIA positivity was 8.1% with huge variability within and between countries. Sixty-one percent of all VIA-positive cases were eligible for immediate TA, and 88% of them accepted same-day treatment. Compliance to TA at PHCs was 99%. Majority of women treated with TA complained of minor side effects. Significant dropouts occurred as the women were referred to colposcopy clinics.

conclusionOpportunistic screening provided as part of routine PHC service can screen many women and treat a significant proportion of screen-positive women with TA with minimal side effects. Primary concerns are the hard-to-reach women who remain out of opportunistic screening coverage and noncompliance of the screen-positive women referred to higher-level centers.

Indexed as

Uterine Cervical NeoplasmsAcetic AcidAdultBeninCote d'IvoireEarly Detection of CancerFemaleHumansMiddle AgedPrimary Health CareSenegalAcetic Acid

Identifiers

PMID36070534
PMCPMC9812504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.